BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 30872332)

  • 1. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
    Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.
    Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of PD-L1 by MicroRNA in Mismatch Repair Deficient-Colorectal Cancer].
    Ashizawa M; Okayama H; Aung Kyi Thar Min ; Noda M; Aoto K; Nakajima T; Ishigame T; Mimura K; Kono K
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):889-891. PubMed ID: 29066686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer.
    Möller K; Blessin NC; Höflmayer D; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Zalewski K; Hinsch A; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Bernreuther C; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Perez D; Izbicki JR; Clauditz TS; Marx AH
    Acta Oncol; 2021 Sep; 60(9):1210-1217. PubMed ID: 34092167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
    Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
    J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.
    Élez E; Mulet-Margalef N; Sanso M; Ruiz-Pace F; Mancuso FM; Comas R; Ros J; Argilés G; Martini G; Sanz-Garcia E; Baraibar I; Salvà F; Noguerido A; Cuadra-Urteaga JL; Fasani R; Garcia A; Jimenez J; Aguilar S; Landolfi S; Hernández-Losa J; Braña I; Nuciforo P; Dienstmann R; Tabernero J; Salazar R; Vivancos A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer.
    Yuan W; Deng D; Jiang H; Tu C; Shang X; He H; Niu R; Dong J
    Cancer Immunol Immunother; 2019 Feb; 68(2):257-268. PubMed ID: 30406373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Miliotis C; Slack FJ
    Cancer Lett; 2021 Oct; 518():115-126. PubMed ID: 34098061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer.
    Yousefi A; Sotoodehnejadnematalahi F; Nafissi N; Zeinali S; Azizi M
    Sci Rep; 2024 Mar; 14(1):5845. PubMed ID: 38462658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer.
    Fu X; Sun G; Tu S; Fang K; Xiong Y; Tu Y; Zha M; Xiao T; Xiao W
    Front Oncol; 2022; 12():877376. PubMed ID: 35712476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1.
    Zhang XL; Xu LL; Wang F
    Cell Biol Int; 2017 Sep; 41(9):1056-1064. PubMed ID: 28707774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
    Chen XY; Zhang J; Hou LD; Zhang R; Chen W; Fan HN; Huang YX; Liu H; Zhu JS
    Int J Immunopathol Pharmacol; 2018; 32():2058738418790318. PubMed ID: 30045644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin resistance in breast cancer xenografts and cell lines can be counterweighted by microRNA-140-3p, through PD-L1 suppression.
    Zhang X; Wang C; Huang C; Yang J; Wang J
    Histol Histopathol; 2023 Oct; 38(10):1193-1204. PubMed ID: 36621840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
    Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
    BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
    Chen YL; Wang GX; Lin BA; Huang JS
    Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and Significance of Molecular Markers in Immunotherapy and Targeted Therapy of Colorectal Cancer in Tibet].
    Luo HH; Liu BY; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Wang H; Guo PP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):184-192. PubMed ID: 38686714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MiR-140-3p Downregulation in Association with PDL-1 Overexpression in Many Cancers: A Review from the Literature Using Predictive Bioinformatics Tools].
    Kapodistrias N; Bobori C; Theocharopoulou G
    Adv Exp Med Biol; 2017; 988():225-233. PubMed ID: 28971402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.